MARC details
| 000 -LEADER |
|---|
| fixed length control field |
10213nam a22003735i 4500 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
EG-CaNGU |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240220112155.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220130t2017 nyua frb 001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781259587481 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1259587487 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
EG-CaNGU |
| Language of cataloging |
eng |
| Transcribing agency |
EG-CaNGU |
| Modifying agency |
EG-CaNGU |
| Description conventions |
rda |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.58 |
| Item number |
PHA |
| Edition number |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Pharmacotherapy : |
| Remainder of title |
a pathophysiologic approach / |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Tenth edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
McGraw-Hill Education, |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2017] |
| 264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2017 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
XXXII, 2474 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
28 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders. Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders -- Chapter 73: Disorders Associated with Intellectual Disabilities -- Section 8: Endocrinologic Disorders -- Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid Disorders -- Chapter 76: Adrenal Gland Disorders -- Chapter e77: Pituitary Gland Disorders -- Section 9: Gynecologic and Obstetric Disorders -- Chapter 78: Pregnancy and Lactation: Therapeutic Considerations -- Chapter 79: Contraception -- Chapter 80: Menstruation-Related Disorders -- Chapter 81: Endometriosis -- Chapter 82: Hormone Therapy in Women -- Section 10: Urologic Disorders -- Chapter 83: Erectile Dysfunction -- Chapter 84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary Incontinence -- Section 11: Immunologic Disorders -- Chapter e86: Function and Evaluation of the Immune System -- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88: Drug Allergy -- Chapter 89: Solid-Organ Transplantation -- Section 12: Rheumatologic Disorders -- Chapter 90: Osteoarthritis -- Chapter 91: Rheumatoid Arthritis -- Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93: Gout and Hyperuricemia -- Section 13: Ophthalmic and Otolaryngological Disorders -- Chapter 94: Glaucoma -- Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97: Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions -- Section 15: Hematologic Disorders -- Chapter 100: Anemias -- Chapter 101: Coagulation Disorders -- Chapter 102: Sickle Cell Disease -- Chapter e103: Drug-Induced Hematologic Disorders -- Section 16: Infectious Diseases -- Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy -- Chapter 105: Antimicrobial Regimen Selection -- Chapter 106: Central Nervous System Infections -- Chapter 107: Lower Respiratory Tract Infections -- Chapter 108: Upper Respiratory Tract Infections -- Chapter 109: Influenza -- Chapter 110: Skin and Soft-Tissue Infections -- Chapter 111: Infective Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings -- Chapter 114: Intra-Abdominal Infections -- Chapter 116: Urinary Tract Infections and Prostatitis -- Chapter e115: Parasitic Diseases -- Chapter 117: Sexually Transmitted Diseases -- Chapter 118: Bone and Joint Infections -- Chapter 119: Sepsis and Septic Shock -- Chapter 120: Superficial Fungal Infections -- Chapter 121: Invasive Fungal Infections -- Chapter 122: Infections in Immunocompromised Patients -- Chapter 123: Antimicrobial Prophylaxis in Surgery -- Chapter e124: Travel Health -- Chapter 125: Vaccines and Immunoglobulins -- Chapter 126: Human Immunodeficiency Virus Infection -- Section 17: Oncologic Disorders -- Chapter 127: Cancer Treatment and Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129: Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter 131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter 133: Ovarian Cancer -- Chapter 134: Acute Leukemias -- Chapter 135: Chronic Leukemias -- Chapter 136: Multiple Myeloma -- Chapter e137: Myelodysplastic Syndromes -- Chapter e138: Renal Cell Carcinoma -- Chapter 139: Melanoma -- Chapter 140: Hematopoietic Stem Cell Transplantation -- Section 18: Nutritional Disorders -- Chapter 141: Assessment of Nutrition Status and Nutrition Requirements -- Chapter 142: Parenteral Nutrition -- Chapter 143: Enteral Nutrition -- Chapter 144: Obesity. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Chemotherapy. |
| Source of heading or term |
NGU-sh |
| 9 (RLIN) |
2257 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drugs |
| General subdivision |
design. |
| Source of heading or term |
NGU-sh |
| 9 (RLIN) |
3332 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
DiPiro, Joseph T., |
| Relator term |
editor. |
| 9 (RLIN) |
4080 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Talbert, Robert L., |
| Relator term |
editor. |
| 9 (RLIN) |
4081 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Yee, Gary C., |
| Relator term |
editor. |
| 9 (RLIN) |
4082 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Matzke, Gary R., |
| Relator term |
editor. |
| 9 (RLIN) |
4083 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Wells, Barbara G., |
| Relator term |
editor. |
| 9 (RLIN) |
4084 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Posey, L. Michael, |
| Relator term |
editor. |
| 9 (RLIN) |
4085 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Ellingrod, Vicki L., |
| Relator term |
associate editor. |
| 9 (RLIN) |
4086 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Nolin, Thomas D., |
| Relator term |
associate editors. |
| 9 (RLIN) |
4087 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Haines, Stuart T., |
| Relator term |
associate editor. |
| 9 (RLIN) |
4088 |